Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics - podcast episode cover

Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics

Jun 11, 201829 minSeason 1Ep. 4
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

On this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before learning about ReviveMed, I knew little about metabolomics. Leila is an articulate and enthusiastic teacher, and her passion is infectious. In this episode, you’ll learn about metabolomics, its potential for disease diagnosis and treatment, and how ReviveMed uses artificial intelligence to realize the opportunities. This episode is brought to you by BenchSci ( www.benchsci.com ). BenchSci uses artificial intelligence to reduce the cost of scientific experiments. Use it to find research antibodies up to 24x faster than using PubMed or Google Scholar. Just enter a protein of interest and filter by technique, organism, tissue, or several other options. BenchSci returns only relevant published figures and products. It’s free for academic researchers. Learn more and sign up at www.benchsci.com .
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics | Artificial Intelligence in Drug Discovery podcast - Listen or read transcript on Metacast